Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association).
Coull
B M
BM
Department of Neurology, Arizona Health Science Center, Tucson, Ariz, USA.
Williams
L S
LS
Goldstein
L B
LB
Meschia
J F
JF
Heitzman
D
D
Chaturvedi
S
S
Johnston
K C
KC
Starkman
S
S
Morgenstern
L B
LB
Wilterdink
J L
JL
Levine
S R
SR
Saver
J L
JL
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D006801:Humans; D015337:Multicenter Studies as Topic / Q000706:statistics & numerical data; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000517:prevention & control; D018570:Risk Assessment; D055502:Secondary Prevention; D020521:Stroke / Q000150:complications / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors